No doubt 2025 will usher in many more advances in CRISPR therapies, thanks to the FDA’s new Platform Technology Designation ...

Inspiratm Technologies OXY B.H.N. Ltd. ("Inspira" or the "Company"), a pioneer in breakthrough life-support technology, today announced positive initial results from its previously reported ...

The ex-vivo testing demonstrated significant bacterial reduction for the innovative IV dressing technology aimed at preventing bloodstream infections in critical patients ...

The University of Oulu is at the forefront of developing cutting-edge biosensor technology that could revolutionize the early ...

More than 600 lung transplants have been performed since Northwestern Medicine launched its lung transplant program back in ...

USAISR is working with MIT Lincoln Lab to develop a new device for providing regional pain control in trauma patients at or ...

The University of Oulu is at the forefront of developing cutting-edge biosensor technology that could revolutionize the early diagnosis and treatment of diseases.

A personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to ...

"Our approach is a remarkable example for a precision medicine of ... More information: Felix Kartnig et al, Ex vivo imaging-based high content phenotyping of patients with rheumatoid arthritis ...

The manuscript addresses the 3D chromatin architecture in monocytes from patients with alcohol-associated hepatitis and its relationship to enhanced transcription of innate immune genes. While the ...

Cell-engineering company, MaxCyte, Inc., announced it will acquire SeQure Dx, which focuses on editing assessment services for cell and gene therapies, for $4.5 million. The all-cash deal includes ...

Operator Good day, and welcome to the Vertex Pharmaceuticals fourth quarter 2024 earnings call. All participants will be in a ...